Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Dennis Meletiche
Biogen Idec, Inc.
United States
Contact
Biogen Idec, Inc.
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
173
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Reconsidering the Economic Value of Therapies for Multiple Sclerosis in the United States: Who Derives Benefit from Medical Technology?
Number of pages: 45
Posted: 24 May 2016
Tiffany Shih
,
Craig Wakeford
, Dennis Meletiche,
Jesse Sussell
,
Adrienne Chung
,
Adrienne Chung
,
Yanmei Liu
,
Jin Joo Shim
and
Darius N. Lakdawalla
Precision Health Economics, Biogen Idec, Inc., Biogen Idec, Inc., Precision Health Economics, IndependentPrecision Health Economics, Precision Health Economics, Precision Health Economics and University of Southern California - Schaeffer Center for Health Policy and Economics
Downloads
173
(435,504)
View PDF
Download
Abstract:
Multiple Sclerosis, social value, insurance value, risk aversion
Feedback
